As per our report, the global ADME toxicology testing market size is estimated to grow a CAGR of 12.2% from 2022 to 2027 and be worth USD 4.77 billion by 2027.
ADME toxicology testing performance is directly dependent on the toxicity of the drug and has lower side effects with high positive results in reducing the health disorder. With increasing concern over animal rights, in vitro technology is highly recommended in almost every laboratory to have better benefits. The prediction technology is all good to have the highest growth rate in the foreseen years with varied advantages. North America accounted for the largest share of the global ADME toxicology testing market in 2021.
The rapid increase in several diseases and the demand for the discovery of new medicines to lower the risk of death and other effects are primarily accelerating the growth of the global ADME toxicology testing market.
The support from the government in investments to launch various new products is impacting the positive development of the global ADME toxicology testing market. The adoption of new techniques in finding a way to launch different products in significantly less time and with lower side effects provides growth opportunities for the market. The reduced cost of affordable medicines by ordinary people due to ADME toxicology testing is lavishing the market's chance to grow extensively.
The global ADME toxicology testing market receives support from technological advancements such as in silico techniques that use computer-based testing methods for faster performance to grow further. Modern cell-based assays are gaining a lot of traction worldwide, and this demand will continue to grow in the future. During the forecast period, ongoing R&D in ADME toxicology testing is expected to open up new opportunities. North America currently has the largest share of the global ADME toxicology testing market, and it is projected to continue to do so in the future.
However, fluctuations in the availability of raw materials are hampering the growth of the market. The increasing prices of pharmaceutical products and violations in following rules and regulations by agencies are challenging factors in the global ADME toxicology testing market.
Several of these techniques require advanced knowledge and software that can manage and store large volumes of data quickly, the lack of in-vitro models to detect autoimmunity and immune stimulation might restrict market expansion to some extent. Furthermore, the market's growth is likely to be hampered by a shortage of efficient software to manage automated robotic arms and liquid handling systems. In the United States, the COVID-19 outbreak has been growing at an exponential rate. This has resulted in a decrease in the number of daily patient visits to hospitals and clinics and a decrease in the number of profiling studies performed under normal conditions. To some extent, this is expected to stifle the global ADME toxicology testing market growth.
High research costs and strict government rules and regulations associated with ADME toxicology testing, on the other hand, are major challenges to the market's expansion. A lack of understanding of the underlying scientific principles and the proper technique selection results in various direct and indirect costs. As a result, highly skilled personnel are required to create, validate, service, and troubleshoot. These are the challenges faced by the ADME toxicology Testing Market.
COVID-19 impact on the global ADME toxicology testing market:
Health supplies and equipment are at risk of running out due to the rapid spread of COVID-19. COVID-19 hasn't had a significant effect on raw material supplies for toxicology technologies, aside from transportation delays caused by travel restrictions and some driver shortage problems. The demand for toxicology technologies, especially diagnostic assays and PCR, has increased, with the demand for faster testing and research in the field. Various diagnostic kits, such as PCR testing panels and medications, have been licensed by the FDA for emergency use in COVID -19 testing and diagnostics. The ADME Toxicology Screening System is an interactive workstation that defines the properties of drug molecules in terms of absorption, distribution, metabolism, and excretion. Furthermore, due to the widespread outbreak of coronavirus disease (COVID-19) and the lack of an effective vaccine or treatment, ADME toxicology testing is being used to assess existing drugs' efficacy as an alternative treatment is increasing market growth.
Market Size Available
2021 to 2027
2022 to 2027
Based on the Method, Technology, End-Users, Application, and Region
Various Analyses Covered
Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities
North America, Europe, Asia Pacific, Latin America, Middle East & Africa
This research report on the global ADME toxicology testing market has been segmented and sub-segmented based on the method, technology, application, end-user, and region.
ADME Toxicology Testing Market – By Method:
The cellular assay segment is expected to occupy a substantial share in the global ADME toxicology testing market based on the product. Factors such as accurate, highly detailed methods are the reason for segment growth. These assays don’t eliminate clinical experiments, but they make human research successful with less risky action to achieve better results.
ADME Toxicology Testing Market – By Technology:
Based on technology, the cell culture segment is predicted to have a dominant share in the global ADME toxicology testing market during the forecast period. From 2D cell culture to 3D cell culture, the transformation is completed where 3D shows the visual result and the skill to test in lower volumes.
ADME Toxicology Testing Market – By Application:
Based on the application, the systemic toxicity segment held a prominent share of the ADME toxicology testing market in 2021. It continued its power and influence throughout the forecast period due to the upward or forward movement in Cardiology's toxicity studies. Systemic toxicity continues to have its power and influence throughout the period. It is the most chosen drug distribution method, which is also one of the crucial causes of toxic reactions. Renal and Hepatotoxicity are the major applications to witness rapid growth in the future.
ADME Toxicology Testing Market – By End-Users:
ADME Toxicology Testing Market – By Region:
Geographically, the global ADME toxicology testing market is looking forward to a steady pace throughout the forecast timespan. North American ADME Toxicology Testing Market is positioned first in holding the highest shares of the global market. The quick adoption of the latest technologies and maintaining strict management rules by the government propel the market demand in this region.
The Asia Pacific and Europe regions are to have dominant shares shortly. Changes in the policies favoring pharmaceutical companies and the growing number of research institutes help the market grow.
KEY MARKET PLAYERS:
Some of the noteworthy companies dominating the global ADME toxicology testing market profiled in this report are Promega Corporation, Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Beckman Coulter, Inc., Cellartis AB, Cyprotex PLC., Life Technologies Corporation, Optivia Biotechnology, Inc., Accelrys, Inc., Molecular Discovery Ltd., Cyprotex PLC and MultiCASE, Inc.
RECENT MARKET HAPPENINGS:
1.1 Market Definition
1.2 Scope of the report
1.3 Study Assumptions
1.4 Base Currency, Base Year and Forecast Periods
2. Research Methodology
2.1 Analysis Design
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Data Modelling
2.2.4 Expert Validation
2.3 Study Timeline
3. Report Overview
3.1 Executive Summary
3.2 Key Inferencees
4. Market Dynamics
4.1 Impact Analysis
4.2 Regulatory Environment
4.3 Technology Timeline & Recent Trends
5. Competitor Benchmarking Analysis
5.1 Key Player Benchmarking
5.1.1 Market share analysis
5.1.3 Regional Presence
5.2 Mergers & Acquistion Landscape
5.3 Joint Ventures & Collaborations
6. Market Segmentation
6.1 ADME Toxicology Testing Market , By Method
6.1.1 Cellular Assay
6.1.2 Biochemical Assay
6.1.3 In Silica
6.1.5 Market Size Estimations & Forecasts (2021-2026)
6.1.6 Y-o-Y Growth Rate Analysis
6.1.7 Market Attractiveness Index
6.2 ADME Toxicology Testing Market , By Technology
6.2.1 Cell Culture
6.2.2 High Throughput
6.2.3 Molecular Imaging
6.2.4 OMICS Technology
6.2.5 Market Size Estimations & Forecasts (2021-2026)
6.2.6 Y-o-Y Growth Rate Analysis
6.2.7 Market Attractiveness Index
6.3 ADME Toxicology Testing Market , By Application
6.3.1 Systemic Toxicity
6.3.2 Renal Toxicity
6.3.6 Market Size Estimations & Forecasts (2021-2026)
6.3.7 Y-o-Y Growth Rate Analysis
6.3.8 Market Attractiveness Index
6.4 ADME Toxicology Testing Market , By End-Users
6.4.1 Hospitals and clinics
6.4.2 Diagnostic centers
6.4.3 Pathological Labs
6.4.5 Market Size Estimations & Forecasts (2021-2026)
6.4.6 Y-o-Y Growth Rate Analysis
6.4.7 Market Attractiveness Index
7. Geographical Landscape
7.1 Global ADME Toxicology Testing Market , by Region
7.2 North America - Market Analysis (2021 - 2026)
7.2.1 By Country
7.2.2 By Method
7.2.3 By Technology
7.2.4 By Application
7.2.5 By End-Users
7.3.1 By Country
126.96.36.199 Rest of Europe
7.3.2 By Method
7.3.3 By Technology
7.3.4 By Application
7.3.5 By End-Users
7.4 Asia Pacific
7.4.1 By Country
188.8.131.52 South Korea
184.108.40.206 South East Asia
220.127.116.11 Australia & NZ
18.104.22.168 Rest of Asia-Pacific
7.4.2 By Method
7.4.3 By Technology
7.4.4 By Application
7.4.5 By End-Users
7.5 Latin America
7.5.1 By Country
22.214.171.124 Rest of Latin America
7.5.2 By Method
7.5.3 By Technology
7.5.4 By Application
7.5.5 By End-Users
7.6 Middle East and Africa
7.6.1 By Country
126.96.36.199 Middle East
7.6.2 By Method
7.6.3 By Technology
7.6.4 By Application
7.6.5 By End-Users
8. Key Player Analysis
8.1 Promega Corporation
8.1.1 Business Description
8.1.4 SWOT Analysis
8.1.5 Recent Developments
8.1.6 Analyst Overview
8.2 Agilent Technologies, Inc.
8.3 Thermo Fisher Scientific, Inc.
8.4 Bio-Rad Laboratories, Inc.
8.5 Beckman Coulter, Inc.
8.6 Cellartis AB
8.7 Cyprotex PLC.
8.8 Life Technologies Corporation
8.9 Optivia Biotechnology, Inc.
8.10 Accelrys, Inc.
8.11 Molecular Discovery Ltd.
8.12 Cyprotex PLC
8.13 MultiCASE, Inc.
9. Market Outlook & Investment Opportunities
List of Tables
List of Figures
The global ADME toxicology testing market size is predicted to be valued at USD 4.77 billion by 2027.
Yes, we have studied and included the COVID-19 impact on the global ADME toxicology testing market in this report.
A significant portion of the global ADME toxicology testing market share was registered by the North American region in 2021.
Promega Corporation, Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Beckman Coulter, Inc., Cellartis AB, Cyprotex PLC., Life Technologies Corporation, Optivia Biotechnology, Inc., Accelrys, Inc., Molecular Discovery Ltd., Cyprotex PLC and MultiCASE, Inc. are some of the key players in the ADME toxicology testing market.
Talk to our analyst and get customised report done according to your research needs
Check if you can avail any discount. Submit your details and our team will get back to you.
Request to avail a free sample report that reflects this market and its growth.